Specific research interests:
- The combined impact of dementia, age-related hearing and vision impairment is the focus of an ambitious European research project, SENSE-Cog: Promoting health for eyes, ears and mind, led by the University of Manchester.
- Neighbourhood and dementia. Keady: PI; Burns, Challis, Davies, Leroi, Nazroo, Pendleton, Reeves, Reilly, Swarbrick, Tampubolon, Taylor, Young: Co-PIs. £4.8m. Funded by the National Institute of Health Research.
- Inequalities in later life, frailty and wellbeing: an interdisciplinary approach to causality. (James Nazroo: PI; Burns, Chandola, Goodacre, Horan, Pendleton, Tampubolon, Wu: Co-PIs. £2.4m. Funded by the Medical Research Council.
Genome-wide association studies (GWAS) of depression, cognition and frailty in older adults using the US Health and Retirement Survey and the English Longitudinal Study of Ageing.
My main work is on health inequalities and understanding causal processes that lead to such inequalities. This is funded by the MRC for 5 years and will analyse data from major industrial countries while focusing on England. We work on the English Longitudinal Study of Ageing, and its counterparts in the U.S., Europe and Australia.
Previous works were broadly in the area of social change. First, I have an ESRC grant [Tampubolon: PI, Mike Savage: Co-PI] to investigate social mobility in Britain over the last quarter of the century using latent growth models. This involves modelling dynamics of inter and intra-generational social class mobility. Additionally, there is an element of inter-cohort as well due to my use of two British cohorts: the National Child Development Study 1958 and the British Cohort Study 1970.
Another extension to standard social mobility study, besides investigating mobility intra-generationally, is to include factors prior to labour market entry which is done within a life course perspective.
Another area of my work draws ideas from the social network analysis. This has been fruitfully applied in the investigation of knowledge growth in some clinical innovations over the last 30 years. I intend to keep working on this separate area of innovation.